Cancer Family
Hepatobiliary Neoplasm
CI-CAN-00000198Explore in graph →
Non-malignant1,187 active trials17 approved drugs42 evidence items
- NCIt
- C8614
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000198Explore in graph →
Clinical trials
5,262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04087876 | Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations | no longer available | — | — | Basilea PharmaceuticaINDUSTRY | 0 | Apr 6, 2025 | clinicaltrials |
| NCT03414489 | Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®) | no longer available | — | — | RedHill Biopharma LimitedINDUSTRY | 0 | Mar 18, 2025 |
| clinicaltrials |
| NCT05683548 | Replicor Compassionate Access Program(RCAP) | no longer available | — | — | Replicor Inc.INDUSTRY | 5 | Feb 17, 2025 | clinicaltrials |
| NCT02960620 | Therasphere for Unresectable Primary or Secondary Liver Neoplasia | no longer available | — | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT00701168 | Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer | no longer available | — | — | Leo W. Jenkins Cancer CenterOTHER | 1 | Aug 23, 2017 | clinicaltrials |
| NCT00589030 | Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | no longer available | — | — | City of Hope Medical CenterOTHER | 1 | Feb 15, 2017 | clinicaltrials |
| NCT02082691 | Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma | no longer available | — | — | Devalingam MahalingamOTHER | 0 | Mar 10, 2014 | clinicaltrials |
| NCT01728051 | Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver | no longer available | — | — | Delcath Systems Inc.INDUSTRY | 1 | Oct 23, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Apr 6, 2025source: clinicaltrials